SEC Info - Achieve Life Sciences, Inc. - ‘10-Q’ for 6/30/22

SEC Info℠

Home

Help

Please Sign In

Achieve Life Sciences, Inc. – ‘10-Q’ for 6/30/22 – ‘EX-101.SCH’

On: Thursday, 8/11/22, at 4:11pm ET · For: 6/30/22 · Accession #: 1564590-22-29122 · File #: 33-80623

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/11/22  Achieve Life Sciences, Inc.       10-Q        6/30/22   60:7.3M                                   ActiveDisclosure/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.15M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 9: R1          Document and Entity Information                     HTML     75K 
10: R2          Consolidated Balance Sheets (Unaudited)             HTML    118K 
11: R3          Consolidated Balance Sheets (Parenthetical)         HTML     39K 
                (Unaudited)                                                      
12: R4          Consolidated Statements of Loss and Comprehensive   HTML     69K 
                Loss (Unaudited)                                                 
13: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML     84K 
14: R6          Consolidated Statements of Stockholder's Equity     HTML     86K 
                (Unaudited)                                                      
15: R7          Nature of Business, Basis of Presentation and       HTML     28K 
                Going Concern Uncertainty                                        
16: R8          Accounting Policies                                 HTML     23K 
17: R9          Government Grant                                    HTML     23K 
18: R10         Intangibles                                         HTML     62K 
19: R11         License Agreements                                  HTML     27K 
20: R12         Fair Value Measurements                             HTML    132K 
21: R13         Convertible Debt                                    HTML     58K 
22: R14         Common Stock                                        HTML    207K 
23: R15         Commitments and Contingencies                       HTML    128K 
24: R16         Intangibles (Tables)                                HTML     62K 
25: R17         Fair Value Measurements (Tables)                    HTML    149K 
26: R18         Convertible Debt (Tables)                           HTML     70K 
27: R19         Common Stock (Tables)                               HTML    186K 
28: R20         Commitments and Contingencies (Tables)              HTML    125K 
29: R21         Nature of Business, Basis of Presentation and       HTML     43K 
                Going Concern Uncertainty - Additional Information               
                (Detail)                                                         
30: R22         Government Grant - Additional Information           HTML     31K 
                (Details)                                                        
31: R23         Intangibles - Additional Information (Detail)       HTML     29K 
32: R24         Intangibles - Components of Intangible Assets       HTML     28K 
                (Detail)                                                         
33: R25         Intangibles - Estimated Future Amortization         HTML     30K 
                Expense Related to Intangible Assets (Detail)                    
34: R26         License Agreements - Additional Information         HTML     27K 
                (Detail)                                                         
35: R27         Fair Value Measurements - Additional Information    HTML     24K 
                (Detail)                                                         
36: R28         Fair Value Measurements - Summary of Assets         HTML     30K 
                Measured at Fair Value on Recurring Basis (Detail)               
37: R29         Fair Value Measurements - Summary of Cash           HTML     27K 
                Equivalents (Detail)                                             
38: R30         Fair Value Measurements - Schedule of Aggregate     HTML     27K 
                Fair Value of Principal Amount of Convertible Debt               
                (Detail)                                                         
39: R31         Convertible Debt - Additional Information           HTML     73K 
                (Details)                                                        
40: R32         Convertible Debt - Schedule of Convertible Debt     HTML     30K 
                Balance (Details)                                                
41: R33         Common Stock - Authorized - Additional Information  HTML     27K 
                (Detail)                                                         
42: R34         Common Stock - Issued and Outstanding Shares -      HTML     57K 
                Additional Information (Detail)                                  
43: R35         Common Stock - Stock Options - Additional           HTML    100K 
                Information (Detail)                                             
44: R36         Common Stock - Summary of Stock Options Activity    HTML     34K 
                (Detail)                                                         
45: R37         Common Stock - Summary of Fair Value of Each Stock  HTML     29K 
                Award for Employees and Directors (Detail)                       
46: R38         Common Stock - Summary of Share-Based Compensation  HTML     27K 
                Expense for Stock Options, Restricted Stock and                  
                Employee Share Purchase Plan (Detail)                            
47: R39         Common Stock - Restricted Stock Unit Awards -       HTML     30K 
                Additional Information (Detail)                                  
48: R40         Common Stock - Summary of Restricted Stock Unit     HTML     37K 
                Award Activity (Detail)                                          
49: R41         Common Stock - Employee Share Purchase Plan -       HTML     24K 
                Additional Information (Detail)                                  
50: R42         Common Stock - Summary of Outstanding Warrants      HTML     52K 
                (Detail)                                                         
51: R43         Common Stock - Common Stock Warrants - Additional   HTML     31K 
                Information (Detail)                                             
52: R44         Commitments and Contingencies - Summary of          HTML     25K 
                Contractual Obligations (Detail)                                 
53: R45         Commitments and Contingencies - Additional          HTML     68K 
                Information (Detail)                                             
54: R46         Commitments and Contingencies - Summary of Future   HTML     26K 
                Minimum Annual Lease Payments (Detail)                           
55: R47         Commitments and Contingencies - Summary of Other    HTML     28K 
                Information Related to Leases (Detail)                           
58: XML         IDEA XML File -- Filing Summary                      XML    109K 
56: XML         XBRL Instance -- achv-10q_20220630_htm               XML   1.57M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     98K 
 5: EX-101.CAL  XBRL Calculations -- achv-20220630_cal               XML    110K 
 6: EX-101.DEF  XBRL Definitions -- achv-20220630_def                XML    496K 
 7: EX-101.LAB  XBRL Labels -- achv-20220630_lab                     XML    967K 
 8: EX-101.PRE  XBRL Presentations -- achv-20220630_pre              XML    710K 
 4: EX-101.SCH  XBRL Schema -- achv-20220630                         XSD    150K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              288±   461K 
60: ZIP         XBRL Zipped Folder -- 0001564590-22-029122-xbrl      Zip    350K

‘EX-101.SCH’ — XBRL Schema — achv-20220630

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:achv="http://achievelifesciences.com/20220630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://achievelifesciences.com/20220630" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>

<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>

<xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>

<xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022"/>

<xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact"/>

<xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated"/>

<xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022"/>

<xsd:annotation>

<xsd:appinfo>

<link:roleType id="TemplateLink" roleURI="http://achievelifesciences.com/20220630/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">

<link:definition> 00000 - Document - Template Link </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple"/>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">

<link:definition> 100000 - Document - Document and Entity Information </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" id="Role_StatementConsolidatedBalanceSheetsUnaudited">

<link:definition> 100010 - Statement - Consolidated Balance Sheets (Unaudited) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/StatementConsolidatedBalanceSheetsParentheticalUnaudited" id="Role_StatementConsolidatedBalanceSheetsParentheticalUnaudited">

<link:definition> 100020 - Statement - Consolidated Balance Sheets (Parenthetical) (Unaudited) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfLossAndComprehensiveLossUnaudited" id="Role_StatementConsolidatedStatementsOfLossAndComprehensiveLossUnaudited">

<link:definition> 100030 - Statement - Consolidated Statements of Loss and Comprehensive Loss (Unaudited) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsUnaudited" id="Role_StatementConsolidatedStatementsOfCashFlowsUnaudited">

<link:definition> 100040 - Statement - Consolidated Statements of Cash Flows (Unaudited) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfStockholderSEquityUnaudited" id="Role_StatementConsolidatedStatementsOfStockholderSEquityUnaudited">

<link:definition> 100050 - Statement - Consolidated Statements of Stockholder's Equity (Unaudited) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndGoingConcernUncertainty" id="Role_DisclosureNatureOfBusinessBasisOfPresentationAndGoingConcernUncertainty">

<link:definition> 100060 - Disclosure - Nature of Business, Basis of Presentation and Going Concern Uncertainty </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureAccountingPolicies" id="Role_DisclosureAccountingPolicies">

<link:definition> 100070 - Disclosure - Accounting Policies </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureGovernmentGrant" id="Role_DisclosureGovernmentGrant">

<link:definition> 100080 - Disclosure - Government Grant </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureIntangibles" id="Role_DisclosureIntangibles">

<link:definition> 100090 - Disclosure - Intangibles </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureLicenseAgreements" id="Role_DisclosureLicenseAgreements">

<link:definition> 100100 - Disclosure - License Agreements </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">

<link:definition> 100110 - Disclosure - Fair Value Measurements </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureConvertibleDebt" id="Role_DisclosureConvertibleDebt">

<link:definition> 100120 - Disclosure - Convertible Debt </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStock" id="Role_DisclosureCommonStock">

<link:definition> 100130 - Disclosure - Common Stock </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">

<link:definition> 100140 - Disclosure - Commitments and Contingencies </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureIntangiblesTables" id="Role_DisclosureIntangiblesTables">

<link:definition> 100150 - Disclosure - Intangibles (Tables) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">

<link:definition> 100160 - Disclosure - Fair Value Measurements (Tables) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureConvertibleDebtTables" id="Role_DisclosureConvertibleDebtTables">

<link:definition> 100170 - Disclosure - Convertible Debt (Tables) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockTables" id="Role_DisclosureCommonStockTables">

<link:definition> 100180 - Disclosure - Common Stock (Tables) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">

<link:definition> 100190 - Disclosure - Commitments and Contingencies (Tables) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureNatureOfBusinessBasisOfPresentationAndGoingConcernUncertaintyAdditionalInformationDetail" id="Role_DisclosureNatureOfBusinessBasisOfPresentationAndGoingConcernUncertaintyAdditionalInformationDetail">

<link:definition> 100200 - Disclosure - Nature of Business, Basis of Presentation and Going Concern Uncertainty - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureGovernmentGrantAdditionalInformationDetails" id="Role_DisclosureGovernmentGrantAdditionalInformationDetails">

<link:definition> 100210 - Disclosure - Government Grant - Additional Information (Details) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureIntangiblesAdditionalInformationDetail" id="Role_DisclosureIntangiblesAdditionalInformationDetail">

<link:definition> 100220 - Disclosure - Intangibles - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureIntangiblesComponentsOfIntangibleAssetsDetail" id="Role_DisclosureIntangiblesComponentsOfIntangibleAssetsDetail">

<link:definition> 100230 - Disclosure - Intangibles - Components of Intangible Assets (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureIntangiblesEstimatedFutureAmortizationExpenseRelatedToIntangibleAssetsDetail" id="Role_DisclosureIntangiblesEstimatedFutureAmortizationExpenseRelatedToIntangibleAssetsDetail">

<link:definition> 100240 - Disclosure - Intangibles - Estimated Future Amortization Expense Related to Intangible Assets (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationDetail" id="Role_DisclosureLicenseAgreementsAdditionalInformationDetail">

<link:definition> 100250 - Disclosure - License Agreements - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetail">

<link:definition> 100260 - Disclosure - Fair Value Measurements - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnRecurringBasisDetail" id="Role_DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnRecurringBasisDetail">

<link:definition> 100270 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value on Recurring Basis (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfCashEquivalentsDetail" id="Role_DisclosureFairValueMeasurementsSummaryOfCashEquivalentsDetail">

<link:definition> 100280 - Disclosure - Fair Value Measurements - Summary of Cash Equivalents (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfPrincipalAmountOfConvertibleDebtDetail" id="Role_DisclosureFairValueMeasurementsScheduleOfAggregateFairValueOfPrincipalAmountOfConvertibleDebtDetail">

<link:definition> 100290 - Disclosure - Fair Value Measurements - Schedule of Aggregate Fair Value of Principal Amount of Convertible Debt (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureConvertibleDebtAdditionalInformationDetails" id="Role_DisclosureConvertibleDebtAdditionalInformationDetails">

<link:definition> 100300 - Disclosure - Convertible Debt - Additional Information (Details) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureConvertibleDebtScheduleOfConvertibleDebtBalanceDetails" id="Role_DisclosureConvertibleDebtScheduleOfConvertibleDebtBalanceDetails">

<link:definition> 100310 - Disclosure - Convertible Debt - Schedule of Convertible Debt Balance (Details) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockAuthorizedAdditionalInformationDetail" id="Role_DisclosureCommonStockAuthorizedAdditionalInformationDetail">

<link:definition> 100320 - Disclosure - Common Stock - Authorized - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockIssuedAndOutstandingSharesAdditionalInformationDetail" id="Role_DisclosureCommonStockIssuedAndOutstandingSharesAdditionalInformationDetail">

<link:definition> 100330 - Disclosure - Common Stock - Issued and Outstanding Shares - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockStockOptionsAdditionalInformationDetail" id="Role_DisclosureCommonStockStockOptionsAdditionalInformationDetail">

<link:definition> 100340 - Disclosure - Common Stock - Stock Options - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockSummaryOfStockOptionsActivityDetail" id="Role_DisclosureCommonStockSummaryOfStockOptionsActivityDetail">

<link:definition> 100350 - Disclosure - Common Stock - Summary of Stock Options Activity (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockSummaryOfFairValueOfEachStockAwardForEmployeesAndDirectorsDetail" id="Role_DisclosureCommonStockSummaryOfFairValueOfEachStockAwardForEmployeesAndDirectorsDetail">

<link:definition> 100360 - Disclosure - Common Stock - Summary of Fair Value of Each Stock Award for Employees and Directors (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockSummaryOfShareBasedCompensationExpenseForStockOptionsRestrictedStockAndEmployeeSharePurchasePlanDetail" id="Role_DisclosureCommonStockSummaryOfShareBasedCompensationExpenseForStockOptionsRestrictedStockAndEmployeeSharePurchasePlanDetail">

<link:definition> 100370 - Disclosure - Common Stock - Summary of Share-Based Compensation Expense for Stock Options, Restricted Stock and Employee Share Purchase Plan (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockRestrictedStockUnitAwardsAdditionalInformationDetail" id="Role_DisclosureCommonStockRestrictedStockUnitAwardsAdditionalInformationDetail">

<link:definition> 100380 - Disclosure - Common Stock - Restricted Stock Unit Awards - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockSummaryOfRestrictedStockUnitAwardActivityDetail" id="Role_DisclosureCommonStockSummaryOfRestrictedStockUnitAwardActivityDetail">

<link:definition> 100390 - Disclosure - Common Stock - Summary of Restricted Stock Unit Award Activity (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockEmployeeSharePurchasePlanAdditionalInformationDetail" id="Role_DisclosureCommonStockEmployeeSharePurchasePlanAdditionalInformationDetail">

<link:definition> 100400 - Disclosure - Common Stock - Employee Share Purchase Plan - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockSummaryOfOutstandingWarrantsDetail" id="Role_DisclosureCommonStockSummaryOfOutstandingWarrantsDetail">

<link:definition> 100410 - Disclosure - Common Stock - Summary of Outstanding Warrants (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommonStockCommonStockWarrantsAdditionalInformationDetail" id="Role_DisclosureCommonStockCommonStockWarrantsAdditionalInformationDetail">

<link:definition> 100420 - Disclosure - Common Stock - Common Stock Warrants - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfContractualObligationsDetail" id="Role_DisclosureCommitmentsAndContingenciesSummaryOfContractualObligationsDetail">

<link:definition> 100430 - Disclosure - Commitments and Contingencies - Summary of Contractual Obligations (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">

<link:definition> 100440 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfFutureMinimumAnnualLeasePaymentsDetail" id="Role_DisclosureCommitmentsAndContingenciesSummaryOfFutureMinimumAnnualLeasePaymentsDetail">

<link:definition> 100450 - Disclosure - Commitments and Contingencies - Summary of Future Minimum Annual Lease Payments (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

<link:roleType roleURI="http://achievelifesciences.com/20220630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfOtherInformationRelatedToLeasesDetail" id="Role_DisclosureCommitmentsAndContingenciesSummaryOfOtherInformationRelatedToLeasesDetail">

<link:definition> 100460 - Disclosure - Commitments and Contingencies - Summary of Other Information Related to Leases (Detail) </link:definition>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

</xsd:appinfo>

</xsd:annotation>

<xsd:element id="achv_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_OtherAssetsAndRestrictedCash" name="OtherAssetsAndRestrictedCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_AccruedLiabilitiesClinicalCurrent" name="AccruedLiabilitiesClinicalCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_PreferredStockSharesDesignated" name="PreferredStockSharesDesignated" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>

<xsd:element id="achv_SharesIssuedAsSettlementWithTradeVendorAsNonMonetaryTransaction" name="SharesIssuedAsSettlementWithTradeVendorAsNonMonetaryTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_AccruedInterestOnSVBConvertibleDebt" name="AccruedInterestOnSVBConvertibleDebt" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_IncreaseDecreaseInGrantsReceivable" name="IncreaseDecreaseInGrantsReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_IncreaseDecreaseInAccruedClinicalLiabilities" name="IncreaseDecreaseInAccruedClinicalLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_IncreaseDecreaseInLeaseObligations" name="IncreaseDecreaseInLeaseObligations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_ProceedsFromAtMarketOffering" name="ProceedsFromAtMarketOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_May2021PublicOfferingMember" name="May2021PublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_SharesIssuedOnExerciseOfWarrants" name="SharesIssuedOnExerciseOfWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_SharesIssuedOnExerciseOfWarrantsValue" name="SharesIssuedOnExerciseOfWarrantsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOfferingShares" name="AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOfferingShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOffering" name="AdjustmentsToAdditionalPaidInCapitalSharesIssuedThroughAtTheMarketOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_StockIssuedDuringPeriodSharesRestrictedStockUnitSettlementWithheldAndRetiredToTreasury" name="StockIssuedDuringPeriodSharesRestrictedStockUnitSettlementWithheldAndRetiredToTreasury" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_StockIssuedDuringPeriodValueRestrictedStockUnitSettlementWithheldAndRetiredToTreasury" name="StockIssuedDuringPeriodValueRestrictedStockUnitSettlementWithheldAndRetiredToTreasury" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_GovernmentGrantsTextBlock" name="GovernmentGrantsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_VancouverOfficeOperatingLeaseMember" name="VancouverOfficeOperatingLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ScheduleOfSupplementalCashFlowsInformationRelatedToLeasesTableTextBlock" name="ScheduleOfSupplementalCashFlowsInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_WorkingCapitalBalance" name="WorkingCapitalBalance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_GrantAwarded" name="GrantAwarded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_GovernmentGrantLineItems" name="GovernmentGrantLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_GovernmentGrantTable" name="GovernmentGrantTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_NationalInstituteOnDrugAbuseMember" name="NationalInstituteOnDrugAbuseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ORCAV1ClinicalStudyCostsMember" name="ORCAV1ClinicalStudyCostsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_NationalInstitutesOfHealthMember" name="NationalInstitutesOfHealthMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ResearchAndDevelopmentExpensesIncreaseDecrease" name="ResearchAndDevelopmentExpensesIncreaseDecrease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_MaximumRequiredPaymentUnderLicenseAgreementUponCompletionOfVariousMilestones" name="MaximumRequiredPaymentUnderLicenseAgreementUponCompletionOfVariousMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_UniversityOfBristolMember" name="UniversityOfBristolMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_AmendmentToLicenseAgreementMember" name="AmendmentToLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_PaymentsUnderLicenseAgreement" name="PaymentsUnderLicenseAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_MaturityPeriodOfSecurities" name="MaturityPeriodOfSecurities" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_RestrictedCashMember" name="RestrictedCashMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_MaximumMaturityPeriodOfCashAndCashEquivalents" name="MaximumMaturityPeriodOfCashAndCashEquivalents" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_ConvertibleDebtLineItems" name="ConvertibleDebtLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ConvertibleDebtTable" name="ConvertibleDebtTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_SiliconValleyBankAndSVBInnovationCreditFundVIIILPMember" name="SiliconValleyBankAndSVBInnovationCreditFundVIIILPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ContingentConvertibleDebtAgreementMember" name="ContingentConvertibleDebtAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_NonConvertibleTermLoansMember" name="NonConvertibleTermLoansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_PrimeRateMinusOnePercentageMember" name="PrimeRateMinusOnePercentageMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_BeforeEighteenMonthAnniversaryMember" name="BeforeEighteenMonthAnniversaryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_AfterEighteenMonthAnniversaryMember" name="AfterEighteenMonthAnniversaryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_DebtInstrumentMaturityDateExtension" name="DebtInstrumentMaturityDateExtension" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_ExtendedPercentageOfAggregatePrincipalAmountOfTermLoanAdvances" name="ExtendedPercentageOfAggregatePrincipalAmountOfTermLoanAdvances" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_MinimumMarketCapitalization" name="MinimumMarketCapitalization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_DebtInstrumentWithdrawalAmount" name="DebtInstrumentWithdrawalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_MayTwoThousandTwentyOnePublicOfferingMember" name="MayTwoThousandTwentyOnePublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_AtMarketSalesAgreementMember" name="AtMarketSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_GrossProceedsFromIssuanceOfCommonStock" name="GrossProceedsFromIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_UnderwritingDiscountsAndCommissionsAndOfferingExpenses" name="UnderwritingDiscountsAndCommissionsAndOfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_CommonStockAggregateMaximumOfferingAmount" name="CommonStockAggregateMaximumOfferingAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_ProceedsFromIssuanceOfCommonStockGross" name="ProceedsFromIssuanceOfCommonStockGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_CommonStockSharesAvailableForFutureGrant" name="CommonStockSharesAvailableForFutureGrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_TwoThousandAndEighteenEquityIncentivePlanMember" name="TwoThousandAndEighteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_BoardOfDirectorsMember" name="BoardOfDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_NewEmployeeInducementGrantsMember" name="NewEmployeeInducementGrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_TwoThousandsAndSeventeenEquityIncentivePlanMember" name="TwoThousandsAndSeventeenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_TwoThousandsAndTenPerformanceIncentivePlanMember" name="TwoThousandsAndTenPerformanceIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ShareBasedCompensationMaximumNumberOfSharesAuthorizedToPurchased" name="ShareBasedCompensationMaximumNumberOfSharesAuthorizedToPurchased" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_ClassOfWarrantsOrRightExpirationDate" name="ClassOfWarrantsOrRightExpirationDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_WarrantsIssuedInSeptemberTwoThousandSeventeenMember" name="WarrantsIssuedInSeptemberTwoThousandSeventeenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInJuneTwoThousandEighteenMember" name="WarrantsIssuedInJuneTwoThousandEighteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInOctoberTwoThousandEighteenMember" name="WarrantsIssuedInOctoberTwoThousandEighteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInMayTwoThousandNinteenMember" name="WarrantsIssuedInMayTwoThousandNinteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInDecemberTwoThousandNineteenMember" name="WarrantsIssuedInDecemberTwoThousandNineteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInAprilTwoThousandTwentyMember" name="WarrantsIssuedInAprilTwoThousandTwentyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInAprilTwoThousandTwenty1Member" name="WarrantsIssuedInAprilTwoThousandTwenty1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInAprilTwoThousandTwenty2Member" name="WarrantsIssuedInAprilTwoThousandTwenty2Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInAugustTwoThousandTwentyMember" name="WarrantsIssuedInAugustTwoThousandTwentyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInDecemberTwoThousandTwentyMember" name="WarrantsIssuedInDecemberTwoThousandTwentyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_WarrantsIssuedInAprilTwoThousandTwentyFinancingMember" name="WarrantsIssuedInAprilTwoThousandTwentyFinancingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ContractualObligationFiscalYearMaturityScheduleLineItems" name="ContractualObligationFiscalYearMaturityScheduleLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_ContractualObligationFiscalYearMaturityScheduleTable" name="ContractualObligationFiscalYearMaturityScheduleTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_LeaseAgreementCommencementDate" name="LeaseAgreementCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_AreaOfOfficeSpaceLeased" name="AreaOfOfficeSpaceLeased" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_OperatingLeaseInitialMonthlyBaseRentExpenses" name="OperatingLeaseInitialMonthlyBaseRentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_OperatingLeaseRevisedMonthlyBaseRentExpenses" name="OperatingLeaseRevisedMonthlyBaseRentExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_OperatingLeaseConstructionAllowance" name="OperatingLeaseConstructionAllowance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>

<xsd:element id="achv_SeattleOfficeOperatingLeaseMember" name="SeattleOfficeOperatingLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_PikeMember" name="PikeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_MonthlyBaseRentalPayments" name="MonthlyBaseRentalPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_MonthlyBaseRentalPaymentsMaximumAnnualIncrease" name="MonthlyBaseRentalPaymentsMaximumAnnualIncrease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_LeaseSecurityDepositAnnualPayment" name="LeaseSecurityDepositAnnualPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>

<xsd:element id="achv_LeaseSecurityDepositYearOne" name="LeaseSecurityDepositYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_LeaseSecurityDepositYearTwo" name="LeaseSecurityDepositYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_LeaseSecurityDepositThereafter" name="LeaseSecurityDepositThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>

<xsd:element id="achv_RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>

<xsd:element id="achv_IndemnificationExpense" name="IndemnificationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>

</xsd:schema>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/12/23  Achieve Life Sciences, Inc.       424B7                  1:173K                                   Donnelley … Solutions/FA
12/29/22  Achieve Life Sciences, Inc.       S-3                    4:276K                                   Donnelley … Solutions/FA

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/27/22  Achieve Life Sciences, Inc.       8-K:1,2,8,9 4/26/22   14:3.8M                                   ActiveDisclosure/FA

↑Top

Filing Submission 0001564590-22-029122 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Achieve Life Sciences, Inc. – ‘10-Q’ for 6/30/22 – ‘EX-101.SCH’

On: Thursday, 8/11/22, at 4:11pm ET · For: 6/30/22 · Accession #: 1564590-22-29122 · File #: 33-80623

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.SCH’ — XBRL Schema — achv-20220630

This Exhibit is an XBRL XML File.

2 Subsequent Filings that Reference this Filing

1 Previous Filing that this Filing References

Quarterly Report — Form 10-Q

Filing Table of Contents